Core Insights - Recursion, a clinical stage TechBio company, has granted inducement restricted stock unit (RSU) awards covering 820,431 shares to 17 new employees as part of its 2024 Inducement Equity Incentive Plan [1][2] Group 1: Inducement RSU Awards - The RSU awards will vest 25% on the first quarterly vesting date after one year from the vesting commencement date, followed by 1/16th of the shares on each subsequent quarterly vesting date [2] - The awards are contingent upon the continued employment of the recipients through the vesting dates and are governed by the terms of the 2024 Plan and grant agreements [2] Group 2: Company Overview - Recursion is focused on decoding biology to improve lives, utilizing a platform known as Recursion OS, which generates one of the largest proprietary biological and chemical datasets [3] - The company employs advanced machine-learning algorithms to identify trillions of relationships in biology and chemistry, free from human bias [3] - Recursion conducts millions of wet lab experiments weekly and operates one of the most powerful supercomputers globally, integrating technology, biology, and chemistry to advance medicine [3] Group 3: Company Location and Presence - Recursion is headquartered in Salt Lake City and is a founding member of BioHive, a collective for the Utah life sciences industry [4] - The company has additional offices in Montréal, New York, London, and the Oxford area [4]